Chronic atrophic gastritis (CAG) is a refractory disease of the digestive system. The basic pathogenesis is the weakness of the spleen and stomach. Although the deficiency can be manifested as a deficiency of qi, blood, yin and yang, the deficiency of qi is the first and foremost, and the liver and stomach are located under the diaphragm and belong to the middle jiao, which are physiologically related and pathologically connected, and are closely related to the movement of qi.CAG caused by liver and stomach can be divided into the following four stages of the disease: liver and stomach qi stagnation if the spleen and stomach qi deficiency is weak to push the liver; liver qi surplus will become fire, liver and stomach heat; liver fire for a long time to hurt the yin spread to the stomach, liver and stomach yin deficiency; CAG onset for a long time, liver blood deficiency, qi and blood deficiency, qi stagnation and blood stasis, then the stomach ligament stasis.Therefore, based on the inheritance and innovation of Ye Tianshi's theory of "liver and stomach treatment", Professor Wang Jiehong took the four syndromes of liver and stomach as the breakthrough point, adhered to the pathogenesis, and used the self-made prescription Zuojin Liujunzi Decoction to add and subtract according to the disease, focusing on From soothing liver qi, reducing stomach turbidity, clearing liver fire, and stomach qi, nourishing liver yin, nourishing stomach yin, nourishing liver blood, and dredging stomach and collaterals, the four methods of treating CAG finally achieve the purpose of treating liver and stomach, and harmonizing qi and blood, in order to effectively reverse The performance of gastric mucosal atrophy under the microscope can be prevented before the disease, and the risk of canceration can be reduced.

Hao Jing, Song Jian. An Analysis of the Experience of Treating Chronic Atrophic Gastritis Based on "Liver and Stomach Treatment". Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 7: 20-25. https://doi.org/10.25236/AJMHS.2023.040704.

[1] Zhang S. S. , Tang X. D. , Huang S. P. , et al. Expert consensus opinion on the diagnosis and treatment of chronic gastritis in Chinese medicine (2017)[J]. Chinese Journal of Traditional Chinese Medicine, 2017, 32(07):3060-3064. 

[2] Wei X. A. Analysis of risk factors for chronic atrophic gastritis and its clinical treatment [J]. Journal of Clinical Rational Drug Use, 2017, 10(36):145-146. 

[3] Liu T Y, Zhuang Y, Dang Y Y, et al. Long-term follow-up study of Helicobacter pylori eradication combined with oral folic acid for 3 months in the treatment of chronic atrophic gastritis [J]. Chinese Journal of Gastroenterology, 2016, 36(11):734-739. 

[4] Correr P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52(24): 6735-6740. 

[5] Ferlay J, Soer Jomataramoer I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methodsand major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5): E359-E386. 

[6] Zhang Y, Ding Y, Zhao Y, et al. Advances in Chinese medicine treatment of chronic atrophic gastritis [J]. Journal of Traditional Chinese Medicine, 2021, 49(12):112-116. 

[7] Zhou Chaohong. Identification and treatment of chronic atrophic gastritis in Chinese and Western medicine [J]. Modern Chinese medicine, 2019, 39(06):73-75+79. 

[8] Cheng Zhuan, Wang Xiaosu. Research progress of Chinese medicine in the treatment of chronic atrophic gastritis [J]. Contemporary Medicine, 2019, 25(32):190-192. 

[9] Huang Y., Pan J. L., Huang C. Y., et al. A literature study on the pattern of evidence and evolution of evidence elements in precancerous lesions of chronic atrophic gastritis[J]. Journal of Traditional Chinese Medicine, 2019, 60(20):1778-1783. 

[10] Wei Wei, Yang Yang. Current status of diagnosis and treatment of chronic atrophic gastritis and the advantages of Chinese medicine treatment [J]. Journal of Traditional Chinese Medicine, 2016, 57(01): 36-40. 

[11] He Weifeng, Li Shuting, Huang Xianwei. Exploration of Ye Tianshi's academic thought of "liver-stomach"[J]. Chinese Ethnic Folk Medicine, 2016, 25(19):1-3. 

[12] (Spring and Autumn) compiled by the Qin Yue people. The Book of Difficulties [M]. Beijing: Science and Technology Literature Press. 1996:9. 

[13] (Qing) Ye Tianshi; Han Fei et al. The medical case of Wujiang Xu Lingtai [M]. Taiyuan: Shanxi Science and Technology Press. 2006:125. 

[14] Zhang Shuo, Zhang Guangcai, Yan Qiaona, et al. Effects of different ratios of Huang Lian and Wu Zhu Zhu on gastric acid secretion and gastric ulcer in rats [J]. Chinese Modern Applied Pharmacology, 2009, 07:535-538. 

[15] Xin G, Zhao XT, Huang XW. Progress in the research of chemical composition and pharmacological effects of Chai Hu [J]. Jilin Chinese Medicine, 2018, 10:1196-1198. 

[16] Jiang A. L. Study on the correlation between Chinese medical evidence and risk factors, endoscopy and pathology in chronic atrophic gastritis [D]. Chinese Academy of Traditional Chinese Medicine, 2020. 

[17] Liang Pinzhen. Study on the efficacy of combining Paeonia lactiflora and Glycyrrhiza glabra soup with Tao Hong Si Wu Tang plus reduction in the treatment of DPN with Western medicine [J]. Clinical Research in Traditional Chinese Medicine, 2017, 18:47-49. 

[18] Han Sijiu. The concoction and applied pharmacology of the Chinese medicine Angelica sinensis [J]. Northern Pharmacology, 2019, 11:194-195. 

[19] Lin Jing. Chinese medicine has advantages in treating stomach diseases [N]. Health Times, 2021-10-15(013).